Short Interest in CellaVision AB (publ) (OTCMKTS:CLVSF) Increases By 228.9%

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 20,112 shares, an increase of 228.9% from the June 15th total of 6,115 shares. Based on an average daily volume of 348 shares, the short-interest ratio is presently 57.8 days.

CellaVision AB (publ) Stock Performance

Shares of CellaVision AB (publ) stock opened at $14.00 on Wednesday. CellaVision AB has a fifty-two week low of $13.49 and a fifty-two week high of $17.30. The company’s 50 day moving average price is $13.58 and its two-hundred day moving average price is $15.27.

About CellaVision AB (publ)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.